Consolidated Cash Flow Statement

for the year ended March 31, 2022

₹ in ‘000s

		Year ended 31.03.2022	Year ended 31.03.2021
Cash flow from/(used in) operating activities
Profit/(loss) before taxes		335,675,367	240,486,799
Adjustments for:
Depreciation and amortisation		14,794,572	14,713,701
Net (appreciation)/depreciation on investments¹		18,320,870	(22,476,697)
Provision in respect of non-performing and other assets		63,775,215	110,315,149
General provision for standard assets		4,065,438	1,569,050
Provision for contingencies & others (including Covid-19 related provision)		16,513,472	53,839,684
(Profit)/loss on sale of fixed assets		(56,635)	63,424
Employees stock options expense		2,669,253	77,611
	(i)	455,757,552	398,588,721
Adjustments for:
(Increase)/decrease in investments		(166,685,392)	90,478,662
(Increase)/decrease in advances		(1,349,047,011)	(968,932,842)
Increase/(decrease) in deposits		1,314,257,752	1,591,555,570
(Increase)/decrease in other assets		46,655,269	4,276,368
Increase/(decrease) in other liabilities and provisions		329,993,864	302,522,352
	(ii)	175,174,482	1,019,900,110
Refund/(payment) of direct taxes	(iii)	(49,817,733)	(38,335,863)
Net cash flow from/(used in) operating activities (i)+(ii)+(iii)	(A)	581,114,301	1,380,152,968
Cash flow from/(used in) investing activities
Purchase of fixed assets		(18,599,746)	(16,882,058)
Proceeds from sale of fixed assets		1,174,397	121,649
(Purchase)/sale of held to maturity securities		(375,789,070)	(613,108,700)
Net cash flow from/(used in) investing activities	(B)	(393,214,419)	(629,869,109)
Cash flow from/(used in) financing activities
Proceeds from issue of share capital (including ESOPs)		7,979,764	154,600,321
Proceeds from long-term borrowings		356,976,668	294,215,131
Repayment of long-term borrowings		(346,030,278)	(527,734,115)
Net proceeds/(repayment) of short-term borrowings		169,436,188	(467,749,038)
Dividend and dividend tax paid		(13,852,335)	-
Net cash flow from/(used in) financing activities	(C)	174,510,007	(546,667,701)
Effect of exchange fluctuation on translation reserve	(D)	(1,268,443)	(6,440,073)
Net increase/(decrease) in cash and cash equivalents (A) + (B) + (C) + (D)		361,141,446	197,176,085
Cash and cash equivalents at beginning of the year		1,475,705,302	1,278,529,217
Less: Reduction due to discontinuation of ICICI Lombard General Insurance Company Limited from consolidation during the year		(5,586,916)	-
Cash and cash equivalents at end of the year		1,831,259,832	1,475,705,302

1. For the year ended March 31, 2021, includes gain on sale of a part of equity investment in ICICI Lombard General Insurance Company Limited, ICICI Prudential Life Insurance Company Limited and ICICI Securities Limited.

2. Cash and cash equivalents include cash in hand, balances with RBI, balances with other banks and money at call and short notice.

As per our Report of even date.

For M S K A & Associates
Chartered Accountants
ICAI Firm Registration no.:
105047W

Tushar Kurani
Partner
Membership no.: 118580

For Khimji Kunverji & Co LLP
Chartered Accountants
ICAI Firm Registration no.:
105146W/W100621

Gautam Shah
Partner
Membership no.: 117348

For and on behalf of the Board of Directors

Girish Chandra Chaturvedi
Chairman
DIN-00110996

Vishakha Mulye
Executive Director
DIN-00203578

Rakesh Jha
Group Chief Financial Officer

Uday M. Chitale
Director
DIN-00043268

Anup Bagchi
Executive Director
DIN-00105962

Ranganath Athreya
Company Secretary

Sandeep Bakhshi
Managing Director & CEO
DIN-00109206

Sandeep Batra
Executive Director
DIN-03620913

Rajendra Khandelwal
Chief Accountant

Mumbai
April 23, 2022